Estados financieros detallados de MiNK Therapeutics, Inc. (INKT): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $11.59, INKT presenta beneficios negativos (P/E no significativo) y un ROE del 83.45%. La capitalización bursátil es de $58M.
Cuenta de Resultados (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $689626 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | 0 | $55060 | $77960 | $121749 | $204617 | $215437 | $181745 |
| Beneficio Bruto | $689626 | -$55060 | -$77960 | -$121749 | -$204617 | -$215437 | -$181745 |
| I+D | $19.7M | $9.5M | $14.0M | $23.1M | $15.5M | $6.3M | $5.76B |
| Generales y Administrativos | $3.8M | $1.2M | $4.6M | $7.7M | $7.4M | $4.1M | $6.73B |
| Gastos Operativos | $23.0M | $10.7M | $18.5M | $30.8M | $22.7M | $10.4M | $12.3M |
| Beneficio Operativo | -$22.3M | -$10.8M | -$18.6M | -$30.9M | -$22.9M | -$10.7M | -$12.5M |
| EBITDA | -$22.2M | -$13.7M | -$27.7M | -$27.9M | -$22.3M | -$10.6M | -$12.3M |
| Gastos por Intereses | $1.6M | $2.4M | $2.4M | $253323 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$23.8M | -$16.2M | -$30.2M | -$28.0M | -$22.5M | -$10.8M | -$12.5M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$23.8M | -$16.2M | -$30.2M | -$28.0M | -$22.5M | -$10.8M | -$12.5M |
| BPA | $-7.80 | $-4.91 | $-9.03 | $-8.31 | $-6.54 | $-2.90 | $-2.93 |
| BPA Diluido | $-10.80 | $-4.91 | $-9.03 | $-8.31 | $-6.54 | $-2.80 | $-2.93 |
| Acciones en Circulación (Diluidas) | $2.4M | $3.3M | $3.3M | $3.4M | $3.4M | $3.9M | $4.3M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$43654 | -$38563 | -$36066 | -$36064 |
| Beneficio Operativo | -$3.0M | -$3.3M | -$2.9M | -$3.2M |
| EBITDA | -$2.8M | -$2.6M | -$2.7M | -$3.2M |
| Beneficio Neto | -$2.9M | -$2.6M | -$2.7M | -$3.1M |
| BPA | $-0.65 | $-0.55 | $-0.57 | $-0.62 |
| BPA Diluido | $-0.65 | $-0.55 | $-0.57 | $-0.62 |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $299036 | $2.7M | $38.9M | $19.6M | $3.4M | $4.6M | $13.4M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $526000 | $254000 | $23000 | 0 | 0 | 0 | 0 |
| Inventario | $87700 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $918400 | $3.6M | $39.6M | $20.4M | $3.6M | $5.0M | $13.8M |
| Inmovilizado Material | $390519 | $458384 | $606595 | $1.1M | $953977 | $732929 | $390869 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $1.3M | $4.6M | $40.2M | $21.5M | $4.6M | $5.7M | $14.2M |
| Cuentas por Pagar | $2.5M | $3.1M | $3.0M | $5.8M | $3.9M | $2.7M | $3.4M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | $5.2M |
| Pasivos Corrientes | $7.4M | $14.2M | $16.5M | $12.7M | $11.4M | $7.0M | $13.0M |
| Deuda a Largo | $26.8M | $43.8M | 0 | 0 | 0 | $4.9M | 0 |
| Pasivos Totales | $37.6M | $58.4M | $16.5M | $21.9M | $22.6M | $25.3M | $28.5M |
| Reservas | -$36.5M | -$52.7M | -$82.9M | -$110.9M | -$133.4M | -$144.2M | -$156.7M |
| Patrimonio Neto | -$36.3M | -$53.9M | $23.8M | -$401303 | -$18.1M | -$19.6M | -$14.2M |
| Deuda Total | $26.8M | $43.8M | 0 | 0 | 0 | $4.9M | $5.2M |
| Deuda Neta | $26.5M | $41.1M | -$38.9M | -$19.6M | -$3.4M | $347572 | -$8.2M |
| Capital Circulante | -$6.5M | -$10.7M | $23.2M | $7.7M | -$7.8M | -$2.0M | $816525 |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $14.3M | $13.4M | $9.5M | $8.8M |
| Activos Totales | $15.0M | $14.2M | $10.4M | $9.6M |
| Pasivos Totales | $28.5M | $28.5M | $23.1M | $23.6M |
| Patrimonio Neto | -$13.5M | -$14.2M | -$12.7M | -$14.0M |
| Deuda Total | $5.7M | $5.2M | 0 | 0 |
Flujo de Caja (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$23.8M | -$16.2M | -$30.2M | -$28.0M | -$22.5M | -$10.8M | -$12.5M |
| Amortizaciones | $36816 | $55060 | $77960 | $121749 | $204617 | $215437 | $181745 |
| Compensación en Acciones | $219571 | $87829 | $1.7M | $3.0M | $3.9M | $1.8M | $2.7M |
| Cambio en Capital Circulante | $4.1M | -$324932 | $3.7M | $8.8M | $2.9M | $459728 | $3.3M |
| Flujo de Caja Operativo | -$14.9M | -$8.3M | -$12.8M | -$18.9M | -$15.8M | -$9.6M | -$5.9M |
| Inversiones (CapEx) | -$426469 | -$95212 | -$248983 | -$250046 | -$73561 | -$4 | 0 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | -$157194 | -$477639 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$15.4M | -$8.4M | -$13.1M | -$19.1M | -$15.8M | -$9.6M | -$5.9M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$941348 | -$2.1M | -$1.7M | -$2.08B |
| Inversiones (CapEx) | 0 | -$3 | 0 | 0 |
| Flujo de Caja Libre | -$941350 | -$2.1M | -$1.7M | -$2.08B |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $620585 | $2.67B | $630386 | $422.2M |
Crecimiento y Márgenes (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | -100.0% | | | | | |
| Crecimiento Beneficio Neto (anual) | | +31.8% | -86.1% | +7.4% | +19.8% | +52.0% | -15.9% |
| Crecimiento BPA (anual) | | +37.1% | -83.9% | +8.0% | +21.3% | +55.7% | -1.0% |
| Cambio en Acciones (anual) | | +37.4% | +1.2% | +0.6% | +2.0% | +12.4% | +10.5% |
| Crecimiento FCF (anual) | | +45.1% | -55.1% | -46.2% | +17.2% | +39.7% | +38.0% |
| Margen Bruto | 100.0% | | | | | | |
| Margen Operativo | -3231.4% | | | | | | |
| Margen EBITDA | -3219.8% | | | | | | |
| Margen Neto | -3451.5% | | | | | | |
| Margen FCF | -2228.9% | | | | | | |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-6.38 | $-2.55 | $-3.91 | $-5.68 | $-4.61 | $-2.47 | $-1.39 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $2.4M | $3.3M | $3.3M | $3.4M | $3.4M | $3.7M | $4.3M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | 83.45% |
| Rentabilidad sobre capital invertido | -604.20% |
| Rentabilidad sobre activos | -118.15% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 1.23 |
Ratios Clave (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -15.38 | -24.44 | -4.94 | -3.14 | -1.64 | -2.40 | -3.81 |
| P/VC | -7.95 | -7.37 | 6.28 | -219.00 | -2.04 | -1.33 | -3.35 |
| P/V | 418.96 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 100.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | -3231.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | -3451.5% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |